vs
Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and WEIBO Corp (WB). Click either name above to swap in a different company.
Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× WEIBO Corp). WEIBO Corp runs the higher net margin — 35.7% vs 3.4%, a 32.3% gap on every dollar of revenue. Over the past eight quarters, WEIBO Corp's revenue compounded faster (22.6% CAGR vs 4.9%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.
OPCH vs WB — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.3B |
| Net Profit | $45.3M | $458.3M |
| Gross Margin | 19.4% | — |
| Operating Margin | 5.4% | 29.1% |
| Net Margin | 3.4% | 35.7% |
| Revenue YoY | 1.3% | — |
| Net Profit YoY | -3.0% | — |
| EPS (diluted) | $0.29 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.4B | $1.3B | ||
| Q2 25 | $1.4B | $841.7M | ||
| Q1 25 | $1.3B | $396.9M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | $1.3B | ||
| Q2 24 | $1.2B | $833.4M |
| Q1 26 | $45.3M | — | ||
| Q4 25 | $58.5M | — | ||
| Q3 25 | $51.8M | $458.3M | ||
| Q2 25 | $50.5M | $234.8M | ||
| Q1 25 | $46.7M | $108.1M | ||
| Q4 24 | $60.1M | — | ||
| Q3 24 | $53.9M | $297.4M | ||
| Q2 24 | $53.0M | $164.6M |
| Q1 26 | 19.4% | — | ||
| Q4 25 | 19.3% | — | ||
| Q3 25 | 19.0% | — | ||
| Q2 25 | 19.0% | — | ||
| Q1 25 | 19.7% | — | ||
| Q4 24 | 21.3% | — | ||
| Q3 24 | 20.1% | — | ||
| Q2 24 | 20.3% | — |
| Q1 26 | 5.4% | — | ||
| Q4 25 | 6.2% | — | ||
| Q3 25 | 5.9% | 29.1% | ||
| Q2 25 | 5.8% | 30.4% | ||
| Q1 25 | 5.9% | 27.8% | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 6.7% | 29.0% | ||
| Q2 24 | 6.6% | 28.2% |
| Q1 26 | 3.4% | — | ||
| Q4 25 | 4.0% | — | ||
| Q3 25 | 3.6% | 35.7% | ||
| Q2 25 | 3.6% | 27.9% | ||
| Q1 25 | 3.5% | 27.2% | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | 4.2% | 22.9% | ||
| Q2 24 | 4.3% | 19.8% |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.37 | — | ||
| Q3 25 | $0.32 | — | ||
| Q2 25 | $0.31 | — | ||
| Q1 25 | $0.28 | — | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.31 | — | ||
| Q2 24 | $0.30 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.3M | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $3.9B |
| Total Assets | $3.4B | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.3M | — | ||
| Q4 25 | $232.6M | — | ||
| Q3 25 | $309.8M | $1.1B | ||
| Q2 25 | $198.8M | $1.2B | ||
| Q1 25 | $171.4M | $1.2B | ||
| Q4 24 | $412.6M | — | ||
| Q3 24 | $483.0M | — | ||
| Q2 24 | $376.9M | $1.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.4B | $3.9B | ||
| Q2 25 | $1.4B | $3.6B | ||
| Q1 25 | $1.4B | $3.5B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | $3.4B |
| Q1 26 | $3.4B | — | ||
| Q4 25 | $3.5B | — | ||
| Q3 25 | $3.5B | $6.9B | ||
| Q2 25 | $3.4B | $6.5B | ||
| Q1 25 | $3.3B | $6.7B | ||
| Q4 24 | $3.4B | — | ||
| Q3 24 | $3.4B | — | ||
| Q2 24 | $3.3B | $7.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.79× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPCH
Segment breakdown not available.
WB
| Income from operations | $373.2M | 29% |
| Shares used in computing diluted net income per share attributable to Weibos shareholders | $268.1M | 21% |
| Shares used in computing basic net income per share attributable to Weibos shareholders | $238.6M | 19% |
| Value-added services | $186.1M | 14% |
| Less: Income tax expenses | $113.2M | 9% |
| Investment related income, net | $45.0M | 4% |
| Product development | $16.7M | 1% |
| General and administrative | $10.6M | 1% |
| Sales and marketing | $7.1M | 1% |
| Accretion to redeemable non-controlling interests | $3.0M | 0% |
